Amedisys Inc. Stock
Amedisys Inc. Stock
The Amedisys Inc. stock is trending slightly upwards today, with an increase of €0.50 (0.570%) compared to yesterday's price.
With 14 Buy predictions and not the single Sell prediction the community is currently very high on Amedisys Inc..
With a target price of 92 € there is a slightly positive potential of 5.14% for Amedisys Inc. compared to the current price of 87.5 €.
Pros and Cons of Amedisys Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Amedisys Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Amedisys Inc. | 0.570% | 0.000% | 4.167% | 25.899% | 3.550% | -58.726% | -13.503% |
Amn Healthcare Svs | -0.400% | -3.137% | -10.182% | -46.304% | -26.269% | -33.691% | 14.101% |
Chemed Corp. | 2.230% | -0.980% | -3.810% | - | - | - | - |
Select Medical Holdings | -1.290% | 3.289% | - | - | - | - | - |
Comments
Amedisys, Inc. (NASDAQ: AMED) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for AMED provided by MarketBeat
Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for AMED provided by MarketBeat
Amedisys, Inc. (NASDAQ: AMED) had its price target raised by analysts at Royal Bank of Canada from $97.00 to $100.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for AMED provided by MarketBeat